Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Product containing guaifenesin and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
sympatomimetikum til respirationssystemet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
naphazolin til respirationssystemet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
phenylephrin mod kongestion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
phenylephrin 0,125 % næsedråber, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
phenylephrin 0,25 % opløsning, næsedråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
phenylephrin 0,5 % opløsning, næsedråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
phenylephrin 1 % opløsning, næsedråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
xylometazolinhydrochlorid 0,05 % næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Ephedrine sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Product containing precisely ephedrine sulfate 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Ephedrine sulfate 2.5 mg/mL nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Ephedrine sulfate 25 mg and guaifenesin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
ephedrinhydrochlorid 8 mg + kaliumiodid 150 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Product containing ephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Product containing ephedrine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
ephedrinsulfat 50 mg/ml injektionsvæske, opløsning, 25 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
ephedrinsulfat 50 mg/ml injektionsvæske, opløsning, 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
natriumcromoglycat + xylometazolinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Antazoline sulfate+xylometazoline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
levalbuterol 0,31 mg/3 ml inhalationsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
levalbuterol 0,63 mg/3 ml inhalationsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
levalbuterol 1,25 mg/3 ml inhalationsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Levosalbutamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
levalbuterol 45 µg med HFA-aerosolinhalator med afmålt dosis |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
accidentel forgiftning med bronkodilator-lægemiddel |
Causative agent |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
1 |
tilsigtet forgiftning med bronkodilator-lægemiddel |
Causative agent |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
1 |
ergoloidmesylater 1,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
ergoloidmesylater 4,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Product containing dihydroergocornine and dihydroergocristine and dihydroergocryptine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Co-dergocrine mesylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Inhaled bronchodilator therapy |
Direct substance |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
1 |
Inhaled bronchodilator therapy |
Direct substance |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
1 |
Inhaled bronchodilator therapy |
Direct substance |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
1 |
allergi over for bronchodilatorpræparater |
Causative agent |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
1 |
Butetamate (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Fenspiride (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Ipratropium bromide anhydrous (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Ipratropium bromide (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Ipratropium bromide monohydrate (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Oxitropium bromide (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Tiotropium bromide (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Tiotropium bromide monohydrate (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Theophylline anhydrous |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Theophylline sodium glycinate (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Ambuphylline |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Theophylline sodium acetate (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Aminophylline (substance) |
Is a |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Theophylline (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Theophylline monohydrate |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Aminophylline hydrate |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Zileuton |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Aminophylline anhydrous |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Choline theophyllinate |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Epinephrine (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Adrenaline hydrochloride |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Bitolterol (substance) |
Is a |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Racepinephrine (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Pseudoephedrine sulfate |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Isoetarine |
Is a |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Epinephrine bitartrate (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Pseudoephedrine (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Epinephrine acetate (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Bitolterol mesilate |
Is a |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Isoetarine hydrochloride (substance) |
Is a |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Isoetarine mesilate |
Is a |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Fenspiride hydrochloride |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Nebivolol hydrochloride (substance) |
Is a |
False |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Diphemanil methylsulfate (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Atropine (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Diphemanil (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Atropine methonitrate (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Umeclidinium (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Umeclidinium bromide (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Atropine sulfate |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Atropine sulfate monohydrate (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Ambroxol acefyllinate |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Doxofylline |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Atropine sulfate anhydrous (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|
Tiotropium bromide anhydrous (substance) |
Is a |
True |
Bronchodilator (substance) |
Inferred relationship |
Some |
|